Results
|
21.
|
Plasma soluble VEGFR-1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancer. [electronic resource] by
- Duda, Dan G
- Willett, Christopher G
- Ancukiewicz, Marek
- di Tomaso, Emmanuelle
- Shah, Mira
- Czito, Brian G
- Bentley, Rex
- Poleski, Martin
- Lauwers, Gregory Y
- Carroll, Madeline
- Tyler, Douglas
- Mantyh, Christopher
- Shellito, Paul
- Clark, Jeffrey W
- Jain, Rakesh K
Producer: 20101014
In:
The oncologist vol. 15
Availability: No items available.
|
|
22.
|
Practice parameters for the management of anal fissures (revised). [electronic resource] by
- Orsay, Charles
- Rakinic, Jan
- Perry, W Brian
- Hyman, Neil
- Buie, Donald
- Cataldo, Peter
- Newstead, Graham
- Dunn, Gary
- Rafferty, Janice
- Ellis, C Neal
- Shellito, Paul
- Gregorcyk, Sharon
- Ternent, Charles
- Kilkenny, John
- Tjandra, Joe
- Ko, Clifford
- Whiteford, Mark
- Nelson, Richard
Producer: 20050203
In:
Diseases of the colon and rectum vol. 47
Availability: No items available.
|
|
23.
|
A safety and survival analysis of neoadjuvant bevacizumab with standard chemoradiation in a phase I/II study compared with standard chemoradiation in locally advanced rectal cancer. [electronic resource] by
- Willett, Christopher G
- Duda, Dan G
- Ancukiewicz, Marek
- Shah, Mira
- Czito, Brian G
- Bentley, Rex
- Poleski, Martin
- Fujita, Hiroshi
- Lauwers, Gregory Y
- Carroll, Madeline
- Tyler, Douglas
- Mantyh, Christopher
- Shellito, Paul
- Chung, Daniel C
- Clark, Jeffrey W
- Jain, Rakesh K
Producer: 20101227
In:
The oncologist vol. 15
Availability: No items available.
|
|
24.
|
Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer. [electronic resource] by
- Xu, Lei
- Duda, Dan G
- di Tomaso, Emmanuelle
- Ancukiewicz, Marek
- Chung, Daniel C
- Lauwers, Gregory Y
- Samuel, Rekha
- Shellito, Paul
- Czito, Brian G
- Lin, Pei-Chun
- Poleski, Martin
- Bentley, Rex
- Clark, Jeffrey W
- Willett, Christopher G
- Jain, Rakesh K
Producer: 20091124
In:
Cancer research vol. 69
Availability: No items available.
|
|
25.
|
Practice parameters for the management of hemorrhoids (revised). [electronic resource] by
- Cataldo, Peter
- Ellis, C Neal
- Gregorcyk, Sharon
- Hyman, Neil
- Buie, W Donald
- Church, James
- Cohen, Jeffrey
- Fleshner, Phillip
- Kilkenny, John
- Ko, Clifford
- Levien, David
- Nelson, Richard
- Newstead, Graham
- Orsay, Charles
- Perry, W Brian
- Rakinic, Jan
- Shellito, Paul
- Strong, Scott
- Ternent, Charles
- Tjandra, Joe
- Whiteford, Mark
Producer: 20050512
In:
Diseases of the colon and rectum vol. 48
Availability: No items available.
|
|
26.
|
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study. [electronic resource] by
- Willett, Christopher G
- Duda, Dan G
- di Tomaso, Emmanuelle
- Boucher, Yves
- Ancukiewicz, Marek
- Sahani, Dushyant V
- Lahdenranta, Johanna
- Chung, Daniel C
- Fischman, Alan J
- Lauwers, Gregory Y
- Shellito, Paul
- Czito, Brian G
- Wong, Terence Z
- Paulson, Erik
- Poleski, Martin
- Vujaskovic, Zeljko
- Bentley, Rex
- Chen, Helen X
- Clark, Jeffrey W
- Jain, Rakesh K
Producer: 20090709
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 27
Availability: No items available.
|
|
27.
|
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. [electronic resource] by
- Willett, Christopher G
- Boucher, Yves
- di Tomaso, Emmanuelle
- Duda, Dan G
- Munn, Lance L
- Tong, Ricky T
- Chung, Daniel C
- Sahani, Dushyant V
- Kalva, Sanjeeva P
- Kozin, Sergey V
- Mino, Mari
- Cohen, Kenneth S
- Scadden, David T
- Hartford, Alan C
- Fischman, Alan J
- Clark, Jeffrey W
- Ryan, David P
- Zhu, Andrew X
- Blaszkowsky, Lawrence S
- Chen, Helen X
- Shellito, Paul C
- Lauwers, Gregory Y
- Jain, Rakesh K
Producer: 20040406
In:
Nature medicine vol. 10
Availability: No items available.
|
|
28.
|
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. [electronic resource] by
- Willett, Christopher G
- Boucher, Yves
- Duda, Dan G
- di Tomaso, Emmanuelle
- Munn, Lance L
- Tong, Ricky T
- Kozin, Sergey V
- Petit, Lucine
- Jain, Rakesh K
- Chung, Daniel C
- Sahani, Dushyant V
- Kalva, Sanjeeva P
- Cohen, Kenneth S
- Scadden, David T
- Fischman, Alan J
- Clark, Jeffrey W
- Ryan, David P
- Zhu, Andrew X
- Blaszkowsky, Lawrence S
- Shellito, Paul C
- Mino-Kenudson, Mari
- Lauwers, Gregory Y
Producer: 20051209
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 23
Availability: No items available.
|
|
29.
|
Practice parameters for the surgical treatment of ulcerative colitis. [electronic resource] by
- Cohen, Jeffrey L
- Strong, Scott A
- Hyman, Neil H
- Buie, W Donald
- Dunn, Gary D
- Ko, Clifford Y
- Fleshner, Phillip R
- Stahl, Thomas J
- Kim, Donald G
- Bastawrous, Amir L
- Perry, W Brian
- Cataldo, Peter A
- Rafferty, Janice F
- Ellis, C Neal
- Rakinic, Jan
- Gregorcyk, Sharon
- Shellito, Paul C
- Kilkenny, John W
- Ternent, Charles A
- Koltun, Walter
- Tjandra, Joe J
- Orsay, Charles P
- Whiteford, Mark H
- Penzer, Jason R
Producer: 20060119
In:
Diseases of the colon and rectum vol. 48
Availability: No items available.
|